Perineural dexamethasone has gained popularity in regional anaesthesia to prolong the duration of analgesia, but its advantage over systemic administration is disputed. The objective of this meta-analysis was to compare the analgesic efficacy of both routes of administration during peripheral nerve block. The methodology followed the PRISMA statement guidelines. The primary outcome was the duration of analgesia analysed according to the type of local anaesthetic administered (bupivacaine or ropivacaine). Secondary outcomes included cumulative opioid consumption in morphine i.v. equivalents, pain scores, and complication rates (neurological complications, infection, or hyperglycaemia). Eleven controlled trials, including 914 patients, were identified. The duration of analgesia was significantly increased with perineural dexamethasone vs systemic dexamethasone by a mean difference of 3 h [95% confidence interval (CI): 1.4, 4.5 h; P¼0.0001]. Subgroup analysis revealed that the duration of analgesia was increased by 21% with bupivacaine (mean difference: 4.0 h; 95% CI: 2.8, 5.2 h; P<0.00001) and 12% with ropivacaine (mean difference: 2.0 h; 95% CI: À0.5, 4.5 h; P¼0.11). The quality of evidence for our primary outcome was moderate according to the GRADE system. There were no significant differences in other secondary outcomes. No neurological complications or infections were reported. Glucose concentrations were not increased when dexamethasone was injected systemically, but this outcome was reported by only two trials. There is, therefore, moderate evidence that perineural dexamethasone combined with bupivacaine, but not ropivacaine, slightly prolongs the duration of analgesia, without an impact on other pain-related outcomes, when compared with systemic dexamethasone. Injection of perineural dexamethasone should be cautiously balanced in light of the off-label indication for this route of administration.
prolongation of block is not fully understood, but suggested possibilities include decreased nociceptive C-fibre activity via a direct effect on glucocorticoid receptors, 4 a direct effect on inhibitory potassium channels, 5 a local vasoconstrictive effect, 6 or a systemic anti-inflammatory effect. 7 Despite the evident clinical benefit, perineural dexamethasone remains an off-label route of administration. An alternative choice of dexamethasone i.v. has likewise been explored, which at moderate doses offers the potential for a systemic anti-inflammatory effect. 8 In a randomized controlled trial, Desmet and colleagues 9 explored both routes of administration and concluded that they offer an equivalent prolongation of analgesia. This early conclusion has been disputed in subsequent trials, 3 10 11 with some authors concluding that additional rigorous assessment of both routes of administration was warranted. 12 The objectives of this meta-analysis were to compare the analgesic efficacy and side-effects of perineural vs systemic dexamethasone administration as an adjunct to local anaesthetic for peripheral nerve block in adult patients.
Methods

Literature search and inclusion criteria
This investigation followed the recommended process described in the 'Preferred Reporting Items for Systematic Reviews and Meta-Analyses' (PRISMA) statement. 13 The authors These search results were combined with Dexamethasone OR Glucocorticoids OR Steroids. Results were further limited by combining with Clinical trials OR Random allocation OR Therapeutic use. The following words were searched as keywords: Anaesth*, Anesth*, Nerve*, Dexamethas*, Glucocort*, Steroid*, Clinical*, Random*, Trial*. The results of this search strategy were limited to randomized controlled trials and humans. No age or language limits were placed on the search. Finally, the references of all articles retrieved from the search were manually scrutinized for any relevant trials not identified using the strategy described above, and Google Scholar TM was examined for any additional publications.
Population
The meta-analysis addresses male and female patients undergoing any surgical operation with a regional nerve block.
Intervention and comparator
Only trials comparing perineural dexamethasone and local anaesthetics with systemic (i.v. or i.m.) dexamethasone and perineural local anaesthetics alone for peripheral nerve block were included in the present meta-analysis.
Outcomes
The specific outcomes sought from each article were derived according to our standard approach, which we described in a previous meta-analysis on acute postoperative pain. 14 The primary outcome was the duration of analgesia or duration of sensory block, defined as the time interval between block performance or onset time of sensory block and the time of first analgesic request or initial pain report. Secondary acute painrelated outcomes were as follows: cumulative morphine i.v. consumption equivalent on postoperative day 1; any pain score recorded at rest and on movement in the early postoperative period (between 0 and 12 h after surgery) and on postoperative days 1 and 2; rates of postoperative nausea and vomiting within the first 24 h after surgery; and patient satisfaction. Secondary side-effect-related outcomes were rates of neurological complication, infection, and hyperglycaemia.
Trial characteristics
Extracted trial characteristics included the following: type of surgery; type of regional block; concentration and volume of local anaesthetics injected; dose of dexamethasone; and use and type of multimodal analgesia.
Rating of the studies
The quality of the research methodology of each randomized trial was assessed following the Cochrane Collaboration's Risk of Bias Tool for randomized controlled trials. 15 Two authors (A.J.-G. and K.R.K.) independently screened, reviewed, and scored the items for each trial using this method and extracted data for the analyses. Disagreements with scoring or extracted data were resolved through discussion with a third author (E.A.).
Data extraction
The source study text, tables, or graphs were used to extract the mean values, SD or SEM, 95% confidence intervals (CI), number of events, and total number of participants. The authors of trials that failed to report the sample size or results as a mean value and SD or SEM or 95% CI were requested twice by mail to give the missing or raw data. If no reply was obtained, the median and interquartile range were used for mean and SD approximations, as follows: the mean was estimated as equivalent to the median and the SD was approximated to be the interquartile range divided by 1.35. 16 All opioids were converted into equi-analgesic doses of morphine i. 21 Results are presented as the mean difference or relative risk (RR) with 95% confidence interval (CI). A two-sided P-value <0.05 was considered significant.
Results
Of the 488 trials identified from the literature search strategy, 11 met the inclusion criteria, representing a total of 914 patients (Fig. 1 ).
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According to our assessment using the Cochrane Collaboration Risk of Bias tool (Fig. 2) , the majority of trials had a low risk of bias. Attempts were made to contact the authors of seven studies, 9 10 22 25-28 and five provided the additional data requested. 9 22 25 27 28 Data were approximated from the median and range in three trials. 10 24 26 Table 1 presents the trial characteristics. All trials combined dexamethasone with long-acting local anaesthetics (bupivacaine or ropivacaine) except one that used a sequential injection of dexamethasone first followed by ropivacaine, without needle tip repositioning between injections. 9 All trials administered systemic dexamethasone i.v. except one that used the i.m. route. 26 Studied doses of dexamethasone were 4, 10 29 5, 11 24 8, 22 23 25-28 and 10 mg. 9 26 One publication presented the results of two randomized controlled trials 26 ; of note, all patients in these two trials received an additional dose of i.v. dexamethasone 8 mg at the end of surgery. 26 Upper limb blocks included interscalene, axillary, supraclavicular, and infraclavicular brachial plexus blocks.
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Lower limb block sites were the adductor canal, sciatic nerve, and ankle. 25-27 29 With the exception of one trial where the authors used a nerve stimulator for block localization, 9 all blocks were performed under ultrasound guidance. Regional block was combined with general anaesthesia in five trials 9 10 24 26 28 and with neuraxial anaesthesia in one. 29 The duration of analgesia was significantly increased by an average of 17% when dexamethasone was injected perineurally vs systemically (mean difference: 3.0 h; 95% CI: 1.4, 4.5 h; P¼0.0001; Fig. 3 ). Subgroup analysis revealed that the mean duration of analgesia with bupivacaine and systemic dexamethasone was 22 trial sequential analysis indicated that firm evidence was reached and that perineural was superior to systemic dexamethasone when combined with bupivacaine ( Supplementary Fig.  S1 ). With ropivacaine, the finding of equivalence between both routes of administration remains underpowered, and a total of 1124 patients would be needed before suggesting a definitive conclusion ( Supplementary Fig. S2 ). The quality of evidence for our primary outcome was moderate according to the GRADE system. With regard to the funnel plots for our primary outcome ( Supplementary Fig. S3 ), the Duval and Tweedie's trim and fill test revealed the point estimates for the combined studies to be 0.40 (95% CI: 0.15, 0.67), suggesting an absence of publication bias. There were no significant differences in the other secondary pain outcomes (Table 2) or side-effects (Table 3 ). Blood glucose concentrations were not increased when dexamethasone was injected systematically compared with the perineural route, but this outcome was reported by only two trials (mean difference À0.8 mmol litre À1 ; 95% CI: À1.8, 0.3 mmol litre À1 ; I 2 ¼89%; P¼0.17; quality of evidence: very low). 9 
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Discussion
This systematic review and meta-analysis compared the analgesic efficacy and side-effects of perineural vs systemic administration of dexamethasone as an adjunct to local anaesthetic for peripheral nerve block in adult patients. Based on 11 randomized controlled trials, including a total of 914 patients, we showed that perineural dexamethasone slightly prolongs duration of analgesia without an impact on other pain-related outcomes and without side-effects. The subgroup analysis demonstrated that the increased duration of analgesia was statistically significant with bupivacaine but not with ropivacaine. A trial sequential analysis revealed that firm evidence was reached for the bupivacaine analysis but that a total of 1124 patients should be accumulated in order to avoid a type II error with ropivacaine. Of note, when ropivacaine, but not bupivacaine, is combined with dexamethasone during in vitro studies, crystallization may occur because of the elevated dexamethasone pH and the incompatibility of ropivacaine with alkaline solutions. 30 Perineural injection of this combination should therefore be cautioned, given the marginal clinical advantage over the systemic route and the 'off-label' nature of this route of administration. Systemic dexamethasone administration at moderate doses is therefore a recommended option that provides effective postoperative analgesia, associated with peripheral nerve block, 31 or not. 8 There are notable limitations to this meta-analysis. First, despite a low risk of bias in the majority of included trials, and with the exception of moderate evidence for the primary outcome, the quality of evidence was low to very low. In addition, variation in the anaesthetic strategies used (i.v. sedation vs general anaesthesia vs spinal anaesthesia) or in the mixtures of local anaesthetics injected (long-acting vs combination of longand short-acting local anaesthetics, with or without epinephrine) may undermine the generalizability of our conclusions. Consequently, the existing literature would benefit from additional trials using a consistent methodology to provide better definition of the clinical benefit of perineural dexamethasone compared with systemic administration. In particular, study methodologies examining peripheral nerve block without additional general or neuraxial anaesthesia would strengthen conclusions with regard to pain scores and opioid consumption. Moreover, we were unable to draw any conclusions regarding the use of dexamethasone when combined with short-or intermediate-acting local anaesthetics, because no trials have investigated these mixtures.
In conclusion, there is moderate evidence that perineural dexamethasone combined with bupivacaine but not with ropivacaine slightly prolongs the duration of analgesia when compared with systemic dexamethasone, without an impact on the other secondary pain-related outcomes. The administration of dexamethasone in this setting should be balanced properly with recognition of the off-label indication of perineural administration and with consideration for the possibility of crystallization when combined with ropivacaine.
